The global Pertussis Vaccine market is projected to reach US$ 6619.4 million by 2030 from an estimated US$ 5384.9 million in 2024, at a CAGR of 3.5% during 2024 and 2030.

Pertussis Vaccine Market

Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.

Global pertussis vaccine key players include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology etc. Global top 2 manufacturers hold a share about 90%. Europe is the largest market, with a share over 30%, followed by North America.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pertussis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Pertussis Vaccine.

The Pertussis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pertussis Vaccine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pertussis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.

Market Segmentation

Scope of Pertussis Vaccine Market Report

Report Metric	Details
Report Name	Pertussis Vaccine Market
Accounted market size in 2024	an estimated US$ 5384.9 in million
Forecasted market size in 2030	US$ 6619.4 million
CAGR	3.5%
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Whole-cell Vaccines Acellular Vaccines
Segment by Application	12 Months Below 12 Months Above
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics, Chengdu Institute of Biological Products
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pertussis Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pertussis Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.

FAQ for this report

How fast is Pertussis Vaccine Market growing?

Ans: The Pertussis Vaccine Market witnessing a CAGR of 3.5% during the forecast period 2024-2030.

What is the Pertussis Vaccine Market size in 2030?

Ans: The Pertussis Vaccine Market size in 2030 will be US$ 6619.4 million.

What is the market share of major companies in Pertussis Vaccine Market?

Ans: Global top 2 manufacturers hold a share about 90%.

Who are the main players in the Pertussis Vaccine Market report?

Ans: The main players in the Pertussis Vaccine Market are Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics, Chengdu Institute of Biological Products

What are the Application segmentation covered in the Pertussis Vaccine Market report?

Ans: The Applications covered in the Pertussis Vaccine Market report are 12 Months Below, 12 Months Above

What are the Type segmentation covered in the Pertussis Vaccine Market report?

Ans: The Types covered in the Pertussis Vaccine Market report are Whole-cell Vaccines, Acellular Vaccines

1 Study Coverage

1.1 Pertussis Vaccine Product Introduction

1.2 Market by Type

1.2.1 Global Pertussis Vaccine Market Size Growth Rate by Type (2019 VS 2023 VS 2030)

1.2.2 Whole-cell Vaccines

1.2.3 Acellular Vaccines

1.3 Market by Application

1.3.1 Global Pertussis Vaccine Market Size Growth Rate by Application (2019 VS 2023 VS 2030)

1.3.2 12 Months Below

1.3.3 12 Months Above

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Pertussis Vaccine Market Size Estimates and Forecasts

2.1.1 Global Pertussis Vaccine Revenue 2019-2030

2.1.2 Global Pertussis Vaccine Sales 2019-2030

2.2 Pertussis Vaccine Market Size by Region: 2023 Versus 2030

2.3 Pertussis Vaccine Sales by Region (2019-2030)

2.3.1 Global Pertussis Vaccine Sales by Region: 2019-2024

2.3.2 Global Pertussis Vaccine Sales Forecast by Region (2025-2030)

2.3.3 Global Pertussis Vaccine Sales Market Share by Region (2019-2030)

2.4 Pertussis Vaccine Market Estimates and Projections by Region (2025-2030)

2.4.1 Global Pertussis Vaccine Revenue by Region: 2019-2024

2.4.2 Global Pertussis Vaccine Revenue Forecast by Region (2025-2030)

2.4.3 Global Pertussis Vaccine Revenue Market Share by Region (2019-2030)

3 Global Pertussis Vaccine by Manufacturers

3.1 Global Top Pertussis Vaccine Manufacturers by Sales

3.1.1 Global Pertussis Vaccine Sales by Manufacturer (2019-2024)

3.1.2 Global Pertussis Vaccine Sales Market Share by Manufacturer (2019-2024)

3.2 Global Top Pertussis Vaccine Manufacturers by Revenue

3.2.1 Global Pertussis Vaccine Revenue by Manufacturer (2019-2024)

3.2.2 Global Pertussis Vaccine Revenue Share by Manufacturer (2019-2024)

3.3 Global Pertussis Vaccine Price by Manufacturer (2019-2024)

3.4 Competitive Landscape

3.4.1 Key Pertussis Vaccine Manufacturers Covered: Ranking by Revenue

3.4.2 Global Pertussis Vaccine Market Concentration Ratio (CR5 and HHI) & (2019-2024)

3.4.3 Global Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.5 Global Pertussis Vaccine Manufacturing Base Distribution, Product Type

3.5.1 Pertussis Vaccine Manufacturers Manufacturing Base Distribution, Headquarters

3.5.2 Manufacturers Pertussis Vaccine Product Type

3.5.3 Date of International Manufacturers Enter into Pertussis Vaccine Market

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles

4.1 Sanofi Pasteur

4.1.1 Sanofi Pasteur Company Information

4.1.2 Sanofi Pasteur Description, Business Overview

4.1.3 Sanofi Pasteur Pertussis Vaccine Products Offered

4.1.4 Sanofi Pasteur Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.1.5 Sanofi Pasteur Pertussis Vaccine Sales by Product in 2023

4.1.6 Sanofi Pasteur Pertussis Vaccine Sales by Application in 2023

4.1.7 Sanofi Pasteur Pertussis Vaccine Sales by Geographic Area in 2023

4.1.8 Sanofi Pasteur Recent Developments

4.2 GSK

4.2.1 GSK Company Information

4.2.2 GSK Description, Business Overview

4.2.3 GSK Pertussis Vaccine Products Offered

4.2.4 GSK Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.2.5 GSK Pertussis Vaccine Sales by Product in 2023

4.2.6 GSK Pertussis Vaccine Sales by Application in 2023

4.2.7 GSK Pertussis Vaccine Sales by Geographic Area in 2023

4.2.8 GSK Recent Developments

4.3 Mitsubishi Tanabe Pharma

4.3.1 Mitsubishi Tanabe Pharma Company Information

4.3.2 Mitsubishi Tanabe Pharma Description, Business Overview

4.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Products Offered

4.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.3.5 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales by Product in 2023

4.3.6 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales by Application in 2023

4.3.7 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales by Geographic Area in 2023

4.3.8 Mitsubishi Tanabe Pharma Recent Developments

4.4 Wuhan Institute of Biological Products

4.4.1 Wuhan Institute of Biological Products Company Information

4.4.2 Wuhan Institute of Biological Products Description, Business Overview

4.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Products Offered

4.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.4.5 Wuhan Institute of Biological Products Pertussis Vaccine Sales by Product in 2023

4.4.6 Wuhan Institute of Biological Products Pertussis Vaccine Sales by Application in 2023

4.4.7 Wuhan Institute of Biological Products Pertussis Vaccine Sales by Geographic Area in 2023

4.4.8 Wuhan Institute of Biological Products Recent Developments

4.5 Walvax Biotechnology

4.5.1 Walvax Biotechnology Company Information

4.5.2 Walvax Biotechnology Description, Business Overview

4.5.3 Walvax Biotechnology Pertussis Vaccine Products Offered

4.5.4 Walvax Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.5.5 Walvax Biotechnology Pertussis Vaccine Sales by Product in 2023

4.5.6 Walvax Biotechnology Pertussis Vaccine Sales by Application in 2023

4.5.7 Walvax Biotechnology Pertussis Vaccine Sales by Geographic Area in 2023

4.5.8 Walvax Biotechnology Recent Developments

4.6 Minhai Biotechnology

4.6.1 Minhai Biotechnology Company Information

4.6.2 Minhai Biotechnology Description, Business Overview

4.6.3 Minhai Biotechnology Pertussis Vaccine Products Offered

4.6.4 Minhai Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.6.5 Minhai Biotechnology Pertussis Vaccine Sales by Product in 2023

4.6.6 Minhai Biotechnology Pertussis Vaccine Sales by Application in 2023

4.6.7 Minhai Biotechnology Pertussis Vaccine Sales by Geographic Area in 2023

4.6.8 Minhai Biotechnology Recent Development

4.7 KM Biologics

4.7.1 KM Biologics Company Information

4.7.2 KM Biologics Description, Business Overview

4.7.3 KM Biologics Pertussis Vaccine Products Offered

4.7.4 KM Biologics Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.7.5 KM Biologics Pertussis Vaccine Sales by Product in 2023

4.7.6 KM Biologics Pertussis Vaccine Sales by Application in 2023

4.7.7 KM Biologics Pertussis Vaccine Sales by Geographic Area in 2023

4.7.8 KM Biologics Recent Development

4.8 Chengdu Institute of Biological Products

4.8.1 Chengdu Institute of Biological Products Company Information

4.8.2 Chengdu Institute of Biological Products Description, Business Overview

4.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Products Offered

4.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.8.5 Chengdu Institute of Biological Products Pertussis Vaccine Sales by Product in 2023

4.8.6 Chengdu Institute of Biological Products Pertussis Vaccine Sales by Application in 2023

4.8.7 Chengdu Institute of Biological Products Pertussis Vaccine Sales by Geographic Area in 2023

4.8.8 Chengdu Institute of Biological Products Recent Development

5 Breakdown Data by Type

5.1 Global Pertussis Vaccine Sales by Type (2019-2030)

5.1.1 Global Pertussis Vaccine Sales by Type (2019-2024)

5.1.2 Global Pertussis Vaccine Sales Forecast by Type (2025-2030)

5.1.3 Global Pertussis Vaccine Sales Market Share by Type (2019-2030)

5.2 Global Pertussis Vaccine Revenue Forecast by Type (2019-2030)

5.2.1 Global Pertussis Vaccine Revenue by Type (2019-2024)

5.2.2 Global Pertussis Vaccine Revenue Forecast by Type (2025-2030)

5.2.3 Global Pertussis Vaccine Revenue Market Share by Type (2019-2030)

5.3 Pertussis Vaccine Average Selling Price (ASP) by Type (2019-2030)

6 Breakdown Data by Application

6.1 Global Pertussis Vaccine Sales by Application (2019-2030)

6.1.1 Global Pertussis Vaccine Sales by Application (2019-2024)

6.1.2 Global Pertussis Vaccine Sales Forecast by Application (2025-2030)

6.1.3 Global Pertussis Vaccine Sales Market Share by Application (2019-2030)

6.2 Global Pertussis Vaccine Revenue Forecast by Application (2019-2030)

6.2.1 Global Pertussis Vaccine Revenue by Application (2019-2024)

6.2.2 Global Pertussis Vaccine Revenue Forecast by Application (2025-2030)

6.2.3 Global Pertussis Vaccine Revenue Market Share by Application (2019-2030)

6.3 Pertussis Vaccine Average Selling Price (ASP) by Application (2019-2030)

7 North America

7.1 North America Pertussis Vaccine Market Size YoY Growth 2019-2030

7.2 North America Pertussis Vaccine Market Facts & Figures by Country

7.2.1 North America Pertussis Vaccine Sales by Country (2019-2030)

7.2.2 North America Pertussis Vaccine Revenue by Country (2019-2030)

7.3 North America Pertussis Vaccine Sales by Type (2019-2024)

7.4 North America Pertussis Vaccine Sales by Application (2019-2024)

8 Asia-Pacific

8.1 Asia-Pacific Pertussis Vaccine Market Size YoY Growth 2019-2030

8.2 Asia-Pacific Pertussis Vaccine Market Facts & Figures by Region

8.2.1 Asia-Pacific Pertussis Vaccine Sales by Region (2019-2030)

8.2.2 Asia-Pacific Pertussis Vaccine Revenue by Region (2019-2030)

8.3 Asia-Pacific Pertussis Vaccine Sales by Type (2019-2024)

8.4 Asia-Pacific Pertussis Vaccine Sales by Application (2019-2024)

9 Europe

9.1 Europe Pertussis Vaccine Market Size YoY Growth 2019-2030

9.2 Europe Pertussis Vaccine Market Facts & Figures by Country

9.2.1 Europe Pertussis Vaccine Sales by Country (2019-2030)

9.2.2 Europe Pertussis Vaccine Revenue by Country (2019-2030)

9.3 Europe Pertussis Vaccine Sales by Type (2019-2024)

9.4 Europe Pertussis Vaccine Sales by Application (2019-2024)

10 Latin America

10.1 Latin America Pertussis Vaccine Market Size YoY Growth 2019-2030

10.2 Latin America Pertussis Vaccine Market Facts & Figures by Country

10.2.1 Latin America Pertussis Vaccine Sales by Country (2019-2030)

10.2.2 Latin America Pertussis Vaccine Revenue by Country (2019-2030)

10.3 Latin America Pertussis Vaccine Sales by Type (2019-2024)

10.4 Latin America Pertussis Vaccine Sales by Application (2019-2024)

11 Middle East and Africa

11.1 Middle East and Africa Pertussis Vaccine Market Size YoY Growth 2019-2030

11.2 Middle East and Africa Pertussis Vaccine Market Facts & Figures by Country

11.2.1 Middle East and Africa Pertussis Vaccine Sales by Country (2019-2030)

11.2.2 Middle East and Africa Pertussis Vaccine Revenue by Country (2019-2030)

11.3 Middle East and Africa Pertussis Vaccine Sales by Type (2019-2024)

11.4 Middle East and Africa Pertussis Vaccine Sales by Application (2019-2024)

12 Supply Chain and Sales Channel Analysis

12.1 Pertussis Vaccine Supply Chain Analysis

12.2 Pertussis Vaccine Key Raw Materials and Upstream Suppliers

12.3 Pertussis Vaccine Clients Analysis

12.4 Pertussis Vaccine Sales Channel and Sales Model Analysis

12.4.1 Pertussis Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales

12.4.2 Pertussis Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales

12.4.3 Pertussis Vaccine Distributors

13 Market Dynamics

13.1 Pertussis Vaccine Industry Trends

13.2 Pertussis Vaccine Market Drivers

13.3 Pertussis Vaccine Market Challenges

13.4 Pertussis Vaccine Market Restraints

14 Research Findings and Conclusion

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Sanofi Pasteur

GSK

Wuhan Institute of Biological Products

Mitsubishi Tanabe Pharma

Walvax Biotechnology

Minhai Biotechnology

KM Biologics

Chengdu Institute of Biological Products

List of Tables

Table 1. Global Pertussis Vaccine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Major Manufacturers of Whole-cell Vaccines

Table 3. Major Manufacturers of Acellular Vaccines

Table 4. Global Pertussis Vaccine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Pertussis Vaccine Market Size by Region (US$ Million): 2023 VS 2030

Table 6. Global Pertussis Vaccine Sales by Region (2019-2024) & (M Doses)

Table 7. Global Pertussis Vaccine Sales Forecast by Region (2025-2030) & (M Doses)

Table 8. Global Pertussis Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 9. Global Pertussis Vaccine Revenue Forecast by Region (2025-2030) & (US$ Million)

Table 10. Global Pertussis Vaccine Sales by Manufacturer (2019-2024) & (M Doses)

Table 11. Global Pertussis Vaccine Sales Share by Manufacturer (2019-2024)

Table 12. Pertussis Vaccine Revenue by Manufacturer (2019-2024) & (US$ Million)

Table 13. Pertussis Vaccine Revenue Share by Manufacturer (2019-2024)

Table 14. Key Manufacturers Pertussis Vaccine Price (2019-2024) & (USD/Doses)

Table 15. Ranking of Global Top Pertussis Vaccine Manufacturers by Revenue (US$ Million) in 2023

Table 16. Global Pertussis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2019-2024)

Table 17. Global Pertussis Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pertussis Vaccine as of 2023)

Table 18. Pertussis Vaccine Manufacturers Manufacturing Base Distribution and Headquarters

Table 19. Manufacturers Pertussis Vaccine Product Type

Table 20. Date of International Manufacturers Enter into Pertussis Vaccine Market

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. Sanofi Pasteur Company Information

Table 23. Sanofi Pasteur Description and Business Overview

Table 24. Sanofi Pasteur Pertussis Vaccine Product

Table 25. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 26. Sanofi Pasteur Sales Proportion of Pertussis Vaccine by Product in 2023

Table 27. Sanofi Pasteur Sales Proportion of Pertussis Vaccine by Application in 2023

Table 28. Sanofi Pasteur Sales Proportion of Pertussis Vaccine by Geographic Area in 2023

Table 29. Sanofi Pasteur Recent Development

Table 30. GSK Company Information

Table 31. GSK Description and Business Overview

Table 32. GSK Pertussis Vaccine Product

Table 33. GSK Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 34. GSK Sales Proportion of Pertussis Vaccine by Product in 2023

Table 35. GSK Sales Proportion of Pertussis Vaccine by Application in 2023

Table 36. GSK Sales Proportion of Pertussis Vaccine by Geographic Area in 2023

Table 37. GSK Recent Development

Table 38. Mitsubishi Tanabe Pharma Company Information

Table 39. Mitsubishi Tanabe Pharma Description and Business Overview

Table 40. Mitsubishi Tanabe Pharma Pertussis Vaccine Product

Table 41. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 42. Mitsubishi Tanabe Pharma Sales Proportion of Pertussis Vaccine by Product in 2023

Table 43. Mitsubishi Tanabe Pharma Sales Proportion of Pertussis Vaccine by Application in 2023

Table 44. Mitsubishi Tanabe Pharma Sales Proportion of Pertussis Vaccine by Geographic Area in 2023

Table 45. Mitsubishi Tanabe Pharma Recent Development

Table 46. Wuhan Institute of Biological Products Company Information

Table 47. Wuhan Institute of Biological Products Description and Business Overview

Table 48. Wuhan Institute of Biological Products Pertussis Vaccine Product

Table 49. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 50. Wuhan Institute of Biological Products Sales Proportion of Pertussis Vaccine by Product in 2023

Table 51. Wuhan Institute of Biological Products Sales Proportion of Pertussis Vaccine by Application in 2023

Table 52. Wuhan Institute of Biological Products Sales Proportion of Pertussis Vaccine by Geographic Area in 2023

Table 53. Wuhan Institute of Biological Products Recent Development

Table 54. Walvax Biotechnology Company Information

Table 55. Walvax Biotechnology Description and Business Overview

Table 56. Walvax Biotechnology Pertussis Vaccine Product

Table 57. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 58. Walvax Biotechnology Sales Proportion of Pertussis Vaccine by Product in 2023

Table 59. Walvax Biotechnology Sales Proportion of Pertussis Vaccine by Application in 2023

Table 60. Walvax Biotechnology Sales Proportion of Pertussis Vaccine by Geographic Area in 2023

Table 61. Walvax Biotechnology Recent Development

Table 62. Minhai Biotechnology Company Information

Table 63. Minhai Biotechnology Description and Business Overview

Table 64. Minhai Biotechnology Pertussis Vaccine Product

Table 65. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 66. Minhai Biotechnology Sales Proportion of Pertussis Vaccine by Product in 2023

Table 67. Minhai Biotechnology Sales Proportion of Pertussis Vaccine by Application in 2023

Table 68. Minhai Biotechnology Sales Proportion of Pertussis Vaccine by Geographic Area in 2023

Table 69. Minhai Biotechnology Recent Development

Table 70. KM Biologics Company Information

Table 71. KM Biologics Description and Business Overview

Table 72. KM Biologics Pertussis Vaccine Product

Table 73. KM Biologics Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 74. KM Biologics Sales Proportion of Pertussis Vaccine by Product in 2023

Table 75. KM Biologics Sales Proportion of Pertussis Vaccine by Application in 2023

Table 76. KM Biologics Sales Proportion of Pertussis Vaccine by Geographic Area in 2023

Table 77. KM Biologics Recent Development

Table 78. Chengdu Institute of Biological Products Company Information

Table 79. Chengdu Institute of Biological Products Description and Business Overview

Table 80. Chengdu Institute of Biological Products Pertussis Vaccine Product

Table 81. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 82. Chengdu Institute of Biological Products Sales Proportion of Pertussis Vaccine by Product in 2023

Table 83. Chengdu Institute of Biological Products Sales Proportion of Pertussis Vaccine by Application in 2023

Table 84. Chengdu Institute of Biological Products Sales Proportion of Pertussis Vaccine by Geographic Area in 2023

Table 85. Chengdu Institute of Biological Products Recent Development

Table 86. Global Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)

Table 87. Global Pertussis Vaccine Sales Forecast by Type (2025-2030) & (M Doses)

Table 88. Global Pertussis Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 89. Global Pertussis Vaccine Revenue Forecast by Type (2025-2030) & (US$ Million)

Table 90. Global Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)

Table 91. Global Pertussis Vaccine Sales Forecast by Application (2025-2030) & (M Doses)

Table 92. Global Pertussis Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 93. Global Pertussis Vaccine Revenue Forecast by Application (2025-2030) & (US$ Million)

Table 94. North America Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)

Table 95. North America Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)

Table 96. North America Pertussis Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 97. North America Pertussis Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 98. North America Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)

Table 99. North America Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)

Table 100. Asia-Pacific Pertussis Vaccine Sales by Region (2019-2024) & (M Doses)

Table 101. Asia-Pacific Pertussis Vaccine Sales by Region (2025-2030) & (M Doses)

Table 102. Asia-Pacific Pertussis Vaccine Revenue by Region (2019-2030) & (US$ Million)

Table 103. Asia-Pacific Pertussis Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 104. Asia-Pacific Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)

Table 105. Asia-Pacific Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)

Table 106. Europe Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)

Table 107. Europe Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)

Table 108. Europe Pertussis Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 109. Europe Pertussis Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 110. Europe Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)

Table 111. Europe Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)

Table 112. Latin America Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)

Table 113. Latin America Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)

Table 114. Latin America Pertussis Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 115. Latin America Pertussis Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 116. Latin America Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)

Table 117. Latin America Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)

Table 118. Middle East and Africa Pertussis Vaccine Sales by Country (2019-2024) & (M Doses)

Table 119. Middle East and Africa Pertussis Vaccine Sales by Country (2025-2030) & (M Doses)

Table 120. Middle East and Africa Pertussis Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 121. Middle East and Africa Pertussis Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 122. Middle East and Africa Pertussis Vaccine Sales by Type (2019-2024) & (M Doses)

Table 123. Middle East and Africa Pertussis Vaccine Sales by Application (2019-2024) & (M Doses)

Table 124. Pertussis Vaccine Key Raw Materials, Industry Status and Trend

Table 125. Pertussis Vaccine Key Raw Materials and Upstream Suppliers

Table 126. Pertussis Vaccine Clients Status and Trend

Table 127. Pertussis Vaccine Typical Clients

Table 128. Pertussis Vaccine Distributors

Table 129. Pertussis Vaccine Market Trends

Table 130. Pertussis Vaccine Market Drivers

Table 131. Pertussis Vaccine Market Challenges

Table 132. Pertussis Vaccine Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Pertussis Vaccine Product Picture

Figure 2. Global Pertussis Vaccine Sales Market Share by Type in 2023 & 2030

Figure 3. Whole-cell Vaccines Product Picture

Figure 4. Acellular Vaccines Product Picture

Figure 5. Global Pertussis Vaccine Sales Market Share by Application in 2023 & 2030

Figure 6. 12 Months Below Examples

Figure 7. 12 Months Above Examples

Figure 8. Pertussis Vaccine Report Years Considered

Figure 9. Global Pertussis Vaccine Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 10. Global Pertussis Vaccine Market Size 2019-2030 (US$ Million)

Figure 11. Global Pertussis Vaccine Sales 2019-2030 (M Doses)

Figure 12. Global Pertussis Vaccine Sales Market Share Forecast by Region (2019-2030)

Figure 13. Global Pertussis Vaccine Revenue Market Share by Region (2019-2030)

Figure 14. Global Pertussis Vaccine Sales Share by Manufacturer in 2023

Figure 15. Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 16. Global Pertussis Vaccine Sales Market Share Forecast by Type (2019-2030)

Figure 17. Global Pertussis Vaccine Revenue Market Share Forecast by Type (2019-2030)

Figure 18. Pertussis Vaccine Average Selling Price (ASP) by Type (2019-2024) & (USD/Doses)

Figure 19. Global Pertussis Vaccine Sales Market Share Forecast by Application (2019-2030)

Figure 20. Global Pertussis Vaccine Revenue Market Share Forecast by Application (2019-2030)

Figure 21. Pertussis Vaccine Average Selling Price (ASP) by Application (2019-2024) & (USD/Doses)

Figure 22. North America Pertussis Vaccine Revenue 2019-2030 (US$ Million)

Figure 23. North America Pertussis Vaccine Sales Market Share by Type (2019-2024)

Figure 24. North America Pertussis Vaccine Sales Market Share by Application (2019-2024)

Figure 25. Asia-Pacific Pertussis Vaccine Revenue 2019-2030 (US$ Million)

Figure 26. Asia-Pacific Pertussis Vaccine Sales Market Share by Region (2019-2030)

Figure 27. Asia-Pacific Pertussis Vaccine Revenue Market Share by Region (2019-2030)

Figure 28. Asia-Pacific Pertussis Vaccine Sales Market Share by Type (2019-2024)

Figure 29. Asia-Pacific Pertussis Vaccine Sales Market Share by Application (2019-2024)

Figure 30. Europe Pertussis Vaccine Revenue Growth Rate 2019-2030 (US$ Million)

Figure 31. Europe Pertussis Vaccine Sales Market Share by Country (2019-2030)

Figure 32. Europe Pertussis Vaccine Revenue Market Share by Country (2019-2030)

Figure 33. Europe Pertussis Vaccine Sales Market Share by Type (2019-2024)

Figure 34. Europe Pertussis Vaccine Sales Market Share by Application (2019-2024)

Figure 35. Latin America Pertussis Vaccine Revenue Growth Rate 2019-2030 (US$ Million)

Figure 36. Latin America Pertussis Vaccine Sales Market Share by Country (2019-2030)

Figure 37. Latin America Pertussis Vaccine Revenue Market Share by Country (2019-2024)

Figure 38. Latin America Pertussis Vaccine Sales Market Share by Type (2019-2024)

Figure 39. Latin America Pertussis Vaccine Sales Market Share by Application (2019-2024)

Figure 40. Middle East and Africa Pertussis Vaccine Revenue Growth Rate 2019-2030 (US$ Million)

Figure 41. Middle East and Africa Pertussis Vaccine Sales Market Share by Country (2019-2030)

Figure 42. Middle East and Africa Pertussis Vaccine Revenue Market Share by Country (2019-2030)

Figure 43. Middle East and Africa Pertussis Vaccine Sales Market Share by Type (2019-2024)

Figure 44. Middle East and Africa Pertussis Vaccine Sales Market Share by Application (2019-2024)

Figure 45. Pertussis Vaccine Supply Chain (Upstream and Downstream Market)

Figure 46. Global Production Market Share of Pertussis Vaccine Raw Materials by Region in 2023

Figure 47. Pertussis Vaccine Distribution Channels

Figure 48. Global Pertussis Vaccine Percentage 2019-2030: Indirect Sales VS Direct Sales

Figure 49. Global Pertussis Vaccine Percentage 2019-2030: Online Sales VS Offline Sales

Figure 50. Bottom-up and Top-down Approaches for This Report

Figure 51. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions